[Drugs for Neglected Diseases Initiative] Geneva, Switzerland (29 November 2019) – The Indian pharmaceutical company Cipla has announced their commitment to price the ground-breaking new product Quadrimune, a “4‑in‑1” treatment for young children with HIV, at below a dollar a day. Quadrimune is currently under review by the US Food and Drug Administration (FDA) for use in children […] Continue reading ->
Madrid – UN Secretary General António Guterres said he is more hopeful about obtaining commitments on climate action from the world’s largest carbon emitters, following the European Commission’s announcement of plans for a European “green pact” – committing Europe to dramatic reductions in its carbon emissions by 2030 and carbon neutrality by 2050. Guterres spoke […] Continue reading ->
African leaders, scientists, and activists are mobilizing to address the scientific, political, and social challenges inherent to ending the HIV epidemic. That was the key message as the 20th International Conference on AIDS and STIs in Africa (ICASA) kicked off on Monday in Kigali, Rwanda under the theme, “AIDS-free Africa: Innovation, Community and Political Leadership.” […] Continue reading ->
The lower house of the French parliament has approved a milestone requirement that pharmaceutical companies must disclose the amount of public funding that was used in the research and development of new medicines entering the national market, as well as allowing those contributions to be factored into negotiations over final drug pricing. After being initially […] Continue reading ->
Global greenhouse gas (GHG) concentrations have reached record-breaking levels again this year, according to the latest annual report on GHG trends by the World Meteorological Organization (WMO).  Publication of the new data in the WMO’s annual Greenhouse Gas Bulletin, comes just a week ahead of the start of the 25th UNFCCC Climate Conference in Madrid, […] Continue reading ->